フルオロウラシル (JP17);
Fluorouracil (JP17/USP/INN)

5−FU (協和キリン), 5−FU (協和キリン), 5−FU (協和キリン)

FLUOROPLEX (Almirall), EFUDEX (Bausch Health US LLC), CARAC (Bausch Health US LLC), TOLAK (HILL DERMACEUTICALS), TOLAK (Pierre Fabre Pharmaceuticals)

FLUOROURACIL (A-S Medication Solutions), FLUOROURACIL (Accord Healthcare), FLUOROURACIL (Accord Healthcare), FLUOROURACIL (BluePoint Laboratories), FLUOROURACIL (BluePoint Laboratories), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Fresenius Kabi USA), FLUOROURACIL (Gland Pharma Limited), FLUOROURACIL (Gland Pharma Limited), FLUOROURACIL (Ingenus Pharmaceuticals), FLUOROURACIL (Ingenus Pharmaceuticals), FLUOROURACIL (Mayne Pharma), FLUOROURACIL CREAM (Mylan Pharmaceuticals), FLUOROURACIL (Mylan Pharmaceuticals), FLUOROURACIL (Sagent Pharmaceuticals), FLUOROURACIL (Spear Dermatology Products), FLUOROURACIL (Spear Dermatology Products), FLUOROURACIL (Taro Pharmaceuticals U.S.A.), FLUOROURACIL (Taro Pharmaceuticals U.S.A.)

C4H3FN2O2

130.0179

130.0772

抗悪性腫瘍薬, 代謝拮抗薬

胃癌 [DS:H00018]
結腸・直腸癌 [DS:H00020]
乳癌 [DS:H00031]
子宮頸癌 [DS:H00030]
子宮体癌 [DS:H00026]
有棘細胞癌 [DS:H00040]
基底細胞癌 [DS:H00039]
肝癌 [DS:H00048]
膵癌 [DS:H00019]
卵巣癌 [DS:H00027]
食道癌 [DS:H00017]
肺癌 [DS:H00013 H00014]
頭頸部癌 [DS:H02420]

TYMS [HSA:7298] [KO:K00560]

Enzyme: DPYD [HSA:1806]

DDI search